
- BioPharm International-06-15-2015
- Volume 2015 eBook
- Issue 1
Taking a “Development-by-Design” Approach to Cell Therapies
Whether outsourcing or developing cell therapies in-house, success demands a focus on quality, cost of goods, and sustainability from the start.
Cell therapies, both autologous and allogeneic, have come a long way in just a few years. Failures, often in clinical stages, have been traced to problems with manufacturing and failure to understand process requirements earlier in the development process.
Download
.
Articles in this issue
over 10 years ago
QRM Tools for Contract Biomanufacturingover 10 years ago
Fill/Finish Trendsover 10 years ago
Biopharma Advances Demand Specialized Expertiseover 10 years ago
Protecting Intellectual Property in Engagements with CMOsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.